Products
Sugammadex is commercially available as a solution for injection (Bridion). It was approved in many countries in January 2010.
Structure and properties
Modified gamma-cyclodextrin.
Effects
Sugammadex (ATC V03AB35) forms a complex with the neuromuscular blocking agents rocuronium or vecuronium in plasma, thus abolishing their effects.
Indications
Abrogation of neuromuscular blockade induced by rocuronium or vecuronium.
